KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Travere Therapeutics (TVTX) over the last 12 years, with Q3 2025 value amounting to -$194000.0.

  • Travere Therapeutics' Change in Inventory fell 17886.18% to -$194000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year decrease of 11373.31%. This contributed to the annual value of $3.8 million for FY2024, which is 9043.38% down from last year.
  • Travere Therapeutics' Change in Inventory amounted to -$194000.0 in Q3 2025, which was down 17886.18% from $19000.0 recorded in Q2 2025.
  • Travere Therapeutics' 5-year Change in Inventory high stood at $22.4 million for Q4 2023, and its period low was -$3.7 million during Q1 2025.
  • Moreover, its 5-year median value for Change in Inventory was $246000.0 (2024), whereas its average is $2.1 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 5902894.74% in 2023, then crashed by 30087.72% in 2025.
  • Quarter analysis of 5 years shows Travere Therapeutics' Change in Inventory stood at -$497000.0 in 2021, then soared by 92.35% to -$38000.0 in 2022, then skyrocketed by 59028.95% to $22.4 million in 2023, then plummeted by 98.73% to $285000.0 in 2024, then plummeted by 168.07% to -$194000.0 in 2025.
  • Its last three reported values are -$194000.0 in Q3 2025, $19000.0 for Q2 2025, and -$3.7 million during Q1 2025.